Deceleration during 'real life' motor vehicle collisions – a sensitive predictor for the risk of sustaining a cervical spine injury?

<p>Abstract</p> <p>Background</p> <p>The predictive value of trauma impact for the severity of whiplash injuries has mainly been investigated in sled- and crash-test studies. However, very little data exist for real-life accidents. Therefore, the predictive value of the trauma impact as assessed by the change in velocity of the car due to the collision (ΔV) for the resulting cervical spine injuries were investigated in 57 cases after real-life car accidents.</p> <p>Methods</p> <p>ΔV was determined for every car and clinical findings related to the cervical spine were assessed and classified according to the Quebec Task Force (QTF).</p> <p>Results</p> <p>In our study, 32 (56%) subjects did not complain about symptoms and were therefore classified as QTF grade 0; 25 (44%) patients complained of neck pain: 8 (14%) were classified as QTF grade I, 6 (10%) as QTF grade II, and 11 (19%) as QTF grade IV. Only a slight correlation (r = 0.55) was found between the reported pain and ΔV. No relevant correlation was found between ΔV and the neck disability index (r = 0.46) and between ΔV and the QTF grade (r = 0.45) for any of the collision types. There was no ΔV threshold associated with acceptable sensitivity and specificity for the prognosis of a cervical spine injury.</p> <p>Conclusion</p> <p>The results of this study indicate that ΔV is not a conclusive predictor for cervical spine injury in real-life motor vehicle accidents. This is of importance for surgeons involved in medicolegal expertise jobs as well as patients who suffer from whiplash-associated disorders (WADs) after motor vehicle accidents.</p> <p>Trial registration</p> <p>The study complied with applicable German law and with the principles of the Helsinki Declaration and was approved by the institutional ethics commission.</p

Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia

<p>Abstract</p> <p>Background</p> <p>We have previously reported that the expression of the messenger ribonucleic acid (mRNA) for the NR2A subunit of the N-methyl-D-aspartate (NMDA) class of glutamate receptor was decreased in a subset of inhibitory interneurons in the cerebral cortex in schizophrenia. In this study, we sought to determine whether a deficit in the expression of NR2A mRNA was present in the subset of interneurons that contain the calcium buffer parvalbumin (PV) and whether this deficit was associated with a reduction in glutamatergic inputs in the prefrontal cortex (PFC) in schizophrenia.</p> <p>Methods</p> <p>We examined the expression of NR2A mRNA, labeled with a ³⁵S-tagged riboprobe, in neurons that expressed PV mRNA, visualized with a digoxigenin-labeled riboprobe via an immunoperoxidase reaction, in twenty schizophrenia and twenty matched normal control subjects. We also immunohistochemically labeled the glutamatergic axon terminals with an antibody against vGluT1.</p> <p>Results</p> <p>The density of the PV neurons that expressed NR2A mRNA was significantly decreased by 48-50% in layers 3 and 4 in the subjects with schizophrenia, but the cellular expression of NR2A mRNA in the PV neurons that exhibited a detectable level of this transcript was unchanged. In addition, the density of vGluT1-immunoreactive boutons was significantly decreased by 79% in layer 3, but was unchanged in layer 5 of the PFC in schizophrenia.</p> <p>Conclusion</p> <p>These findings suggest that glutamatergic neurotransmission via NR2A-containing NMDA receptors on PV neurons in the PFC may be deficient in schizophrenia. This may disinhibit the postsynaptic excitatory circuits, contributing to neuronal injury, aberrant information flow and PFC functional deficits in schizophrenia.</p

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

Sustainable Entrepreneurship: The Role of Perceived Barriers and Risk

FdR – Publicaties niet-programma gebonde

Management theories linking individual and organizational level analysis in entrepreneurship research

This paper carries out a bibliographical review of the evolution of the individual level research, the new individual approaches and analyzes possible methods for the extension of entrepreneurship research to the organizational level. We also discuss about the suitability of the resource based view and network approaches. We review the management theories and paradigms which are capable of incorporating and linking individual and organizational level studies to the external context where entrepreneurs compete and seek opportunities. In this sense we refer to the resource based view and the network theory as they have been deemed the most adequate to incorporate micro level theories through a convergence of concepts, rather than by a combination or confrontation of ideas. The linking concepts of the individual and firm level theories are presented as an evolution of entrepreneurship research in a specific direction, showing the common ideas shared in the convergent point.Canina, L.; Palacios Marqués, D.; Devece Carañana, CA. (2012). Management theories linking individual and organizational level analysis in entrepreneurship research. International Entrepreneurship and Management Journal. 8(3):271-284. doi:10.1007/s11365-010-0166-8S27128483Auerswald, P. (2008). Entrepreneurship in the theory of the firm. Small Business Economics, 30(2), 111–126.Baron, R. A. (2009). Effectual versus predictive logics in entrepreneurial decision making: differences between experts and novices: does experience in starting new ventures change the way entrepreneurs think? Perhaps, but for now, “Caution” is essential. Journal of Business Venturing, 24(4), 310–315.Bowman, C., & Ambrosini, V. (2000). Value creation versus value capture: towards a coherent definition of value in strategy. British Journal of Management, 11(1), 1–15.Bratkovic, T., Antoncic, B., & Ruzzier, M. (2009). Strategic utilization of entrepreneur’s resource-based social capital and small firm growth. Journal of Management and Organization, 15(4), 486–499.Caliendo, M., Fossen, F., & Kritikos, A. (2009). Risk attitudes of nascent entrepreneurs—new evidence from an experimentally validated survey. Small Business Economics, 32(2), 153–167.Chiles, T. H., Vulture, D. M., Gupta, V. K., Greening, D. W., & Tuggle, C. S. (2010). The philosophical foundations of a radical Austrian approach to entrepreneurship. Journal of Management Inquiry, 19(2), 138–164.Davidsson, P., & Wiklund, J. (2001). Levels of analysis in entrepreneurship research: current research practice and suggestions for the future. Entrepreneurship: Theory & Practice, 6(2), 81–99.Davidsson, P., Delmar, F., & Wiklund, J. (2006). Entrepreneurship as growth; growth as entrepreneurship. In P. Davidsson, F. Delmar, & J. Wiklund (Eds.), Entrepreneurship and the growth of firms (pp. 21–38). Cheltenham: Edward Elgar Publisher.Dierickx, I., & Cool, K. (1989). Asset stock accumulation and sustainability of competitive advantage. Management Science, 35(12), 1504–1511.Franco, M., & Haase, H. (2010). Failure factors in small and medium-sized enterprises: qualitative study from an attributional perspective. International Entrepreneurship and Management Journal, 6(4), 503–521.Fuentes, M., Ruiz, M., Bojica, A., & Fernandez, V. (2010). Prior knowledge and social networks in the exploitation of entrepreneurial opportunities. International Entrepreneurship and Management Journal, 6(4), 481–501.Fuller-Love, N. (2009). Formal and informal networks in small businesses in the media industry. International Entrepreneurship and Management Journal, 5(3), 271–284.Gartner, W. B. (1988). Who is the entrepreneur? Is the wrong question. American Journal of Business, 12(14), 11–32.Gnyawali, D. R., & Fogel, D. S. (1994). Environments for entrepreneurship development: key dimensions and research implications. Entrepreneurship: Theory and Practice, 18(4), 43–62.Grant, R. M. (1991). The resource-based theory of competitive advantage: implications for strategy formulation. California Management Review, 33(3), 114–135.Hamel, G., & Prahalad, C. K. (1994). Competing for the future. Boston: Harvard Business School Press.Henley, A. (2007). Entrepreneurial aspiration and transition into self-employment: evidence from British longitudinal data. Entrepreneurship & Regional Development, 19(3), 253–280.Hoang, H., & Antoncic, B. (2003). Network-based research in entrepreneurship: a critical review. Journal of Business Venturing, 18(2), 165–187.Locke, E. A., & Latham, G. P. (1990). A theory of goal setting and task performance. Englewood Cliffs: Prentice Hall.Low, M. B., & MacMillan, I. C. (1988). Entrepreneurship: past research and future challenges. Journal of Management, 14(2), 139–161.McGee, J. E., Peterson, M., Mueller, S. L., & Sequeira, J. M. (2009). Entrepreneurial self-efficacy: refining the measure. Entrepreneurship: Theory & Practice, 33(4), 965–988.Mitchell, R. K., Busenitz, L., Lant, T., McDougall, P. P., Morse, E. A., & Smith, J. B. (2002). Toward a theory of entrepreneurial cognition: rethinking the people side of entrepreneurship research. Entrepreneurship: Theory & Practice, 27(2), 93–104.Mueller, S. L., & Goic, S. (2003). East–West differences in entrepreneurial self-efficacy: implications for entrepreneurship education in transition economies. International Journal of Entrepreneurship Education, 1(4), 613–632.Pruitt, D. G. (1981). Negotiation behavior. New York: Academic.Rauch, A., & Frese, M. (2007). Let’s put the person back into entrepreneurship research: a meta-analysis on the relationship between business owners’ personality traits, business creation, and success. European Journal of Work and Organizational Psychology, 16(4), 353–385.Rodriguez, A., Rodriguez, A., & Murillo, G. (2010). New perspectives for the managerial entrepreneurship. International Entrepreneurship and Management Journal, 6(2), 203–219.Schindehutte, M., & Morris, M. H. (2009). Advancing strategic entrepreneurship research: the role of complexity science in shifting the paradigm. Entrepreneurship: Theory & Practice, 33(1), 241–276.Shane, S., & Venkataraman, S. (2000). The promise of entrepreneurship as a field of research. Academy of Management Review, 25(1), 217–226.Shook, C. L., Priem, R. L., & McGee, J. E. (2003). Venture creation and the enterprising individual: a review and synthesis. Journal of Management, 29(3), 379–399.Stajkovic, A. D., & Luthans, F. (1997). A meta-analysis of the effects of organizational behavior modification on task performance, 1975–95. Academy of Management Journal, 40(5), 1122–1149.Thurik, A. R., & Wennekers, A. (2004). Entrepreneurship, small business and economic growth. Journal of Small Business and Enterprise Development, 11(1), 140–149.Tolstoy, D. (2010). Knowledge combination in networks: evidence from the international venturing of four small biotech firms. International Entrepreneurship and Management Journal, 6(2), 183–202.van Stel, A. J. (2006). Empirical analysis of entrepreneurship and economic growth (International studies in entrepreneurship series, vol. 13). New York: Springer Science.Veciana, J. M., & Urbano, D. (2008). The institutional approach to entrepreneurship research. Introduction. International Entrepreneurship and Management Journal, 4(4), 365–379.Welter, F., & Lasch, F. (2008). Entrepreneurship research in Europe: taking stock and looking forward. Entrepreneurship: Theory & Practice, 32(2), 241–248.West, G. P., III. (2003). Connecting levels of analysis in entrepreneurship research: a focus on information processing, asymmetric knowledge and networks. In C. Steyaert & D. Hjorth (Eds.), New movements in entrepreneurship (pp. 51–70). London: Edward Elgar.Westhead, P. (2008). Entrepreneurship: concepts, theory and perspectives. International Small Business Journal, 26(2), 251–255.Westlund, H., & Bolton, R. (2003). Local social capital and entrepreneurship. Small Business Economics, 21(2), 77–113.Wright, M., Hoskisson, R. E., Busenitz, L. W., & Dial, J. (2000). Entrepreneurial growth through privatizations: the upside of management buyouts. Academy of Management Review, 25(3), 591–601.Zhao, H., Seibert, C., & Hills, C. (2005). The mediating role of self-efficacy in the development of entrepreneurial intentions. Journal of Applied Psychology, 90(2), 1265–1272.Zimmerman, M. A., & Zeitz, G. J. (2002). Beyond survival: achieving new venture growth by building legitimacy. Academy of Management Review, 27(3), 414–431